Context Therapeutics Statistics Share Statistics Context Therapeutics has 89.7M
shares outstanding. The number of shares has increased by 19.61%
in one year.
Shares Outstanding 89.7M Shares Change (YoY) 19.61% Shares Change (QoQ) 0% Owned by Institutions (%) 75.02% Shares Floating 57.81M Failed to Deliver (FTD) Shares 946,186 FTD / Avg. Volume 402.99%
Short Selling Information The latest short interest is 1.6M, so 1.78% of the outstanding
shares have been sold short.
Short Interest 1.6M Short % of Shares Out 1.78% Short % of Float 2.16% Short Ratio (days to cover) 9.4
Valuation Ratios The PE ratio is -2.3 and the forward
PE ratio is -2.57.
Context Therapeutics's PEG ratio is
0.03.
PE Ratio -2.3 Forward PE -2.57 PS Ratio 0 Forward PS 30.3 PB Ratio 0.64 P/FCF Ratio -2.09 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Context Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 35.62,
with a Debt / Equity ratio of 0.
Current Ratio 35.62 Quick Ratio 35.62 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.23M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -71.55% in the
last 52 weeks. The beta is 1.89, so Context Therapeutics's
price volatility has been higher than the market average.
Beta 1.89 52-Week Price Change -71.55% 50-Day Moving Average 0.69 200-Day Moving Average 1.01 Relative Strength Index (RSI) 46.78 Average Volume (20 Days) 234,793
Income Statement
Revenue n/a Gross Profit n/a Operating Income -29.92M Net Income -26.73M EBITDA -26.67M EBIT -26.73M Earnings Per Share (EPS) -0.46
Full Income Statement Balance Sheet The company has 94.43M in cash and 219.38K in
debt, giving a net cash position of 94.21M.
Cash & Cash Equivalents 94.43M Total Debt 219.38K Net Cash 94.21M Retained Earnings -94.78M Total Assets 87.15M Working Capital 82.39M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.56M
and capital expenditures -14.76M, giving a free cash flow of -29.31M.
Operating Cash Flow -14.56M Capital Expenditures -14.76M Free Cash Flow -29.31M FCF Per Share -0.5
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
